Ketamine and Propofol Protect Neuron Cells from Oxygen-Glucose Deprivation-Induced Injury through SAPKJNK Signalling Pathway

Abstract EN

Ketamine and propofol are commonly used anaesthetic reagents.

Recent research revealed that ketamine and propofol have an important role in cell survival.

However, it remains unknown whether they affect the outcome of hypoxic-ischemic brain injury.

To address this issue, we in this study investigated the effects of ketamine and propofol on the survival and proliferation of neuronal PC12 cells after exposure to oxygen-glucose deprivation- (OGD-) induced injury.

PC12 cells were maintained under a 3-dimensional (3D) culture system to mimic a real physiological microenvironment.

The cell injury was induced by 5% CO2 and 95% N2 for a different time point.

MTT assay was used for the cell proliferation assay.

The cell apoptosis was evaluated by annexin V and propidium iodide (PI) labeling, immunofluorescence staining, transmission electron microscopy (TEM), flow cytometry, and Western blot, respectively.

Our results showed that PC12 cell apoptosis was significantly increased for up to 70% after the cells were treated with OGD for 24 hours and reduced to baseline at the 72-hour time point.

However, pretreatment with ketamine and propofol significantly protected the cells from OGD-induced cell apoptosis, as evidenced by more expression of antiapoptotic Bcl-2 and lower expression of proapoptotic cleaved caspase-3, phosphor-SAPK/JNK, and phosphor-c-Jun than those of untreated control cells.

Thus, we conclude that ketamine and propofol protected PC12 cells from OGD-induced cell apoptosis, at least partially through the SAPK/JNK signalling pathway.